Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Urologic Oncology
|
March 27, 2019
Expression and prognostic utility of PD-L1 in patients with squamous cell carcinoma of the bladder
Michael Owyong, Yair Lotan, Payal Kapur, et al.
Arxiv
|
June 10, 2024
Histopathology Based AI Model Predicts Anti-Angiogenic Therapy Response in Renal Cancer Clinical Trial
Jay Jasti, Hua Zhong, Vandana Panwar, et al.
Nature Communications
|
March 18, 2025
Histopathology based AI model predicts anti-angiogenic therapy response in renal cancer clinical trial
Jay Jasti, Hua Zhong, Vandana Panwar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 5, 2017
Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma
Thai Huu Ho, Payal Kapur, Jeanette E Eckel-Passow, et al.
Journal of Cellular Physiology
|
August 12, 2020
SPARC is a key mediator of TGF-β-induced renal cancer metastasis
Ji-Ming Bao, Qiang Dang, Chun-Jung Lin, et al.
Urologic Oncology
|
May 12, 2018
Multi-institutional evaluation of the prognostic significance of EZH2 expression in high-grade upper tract urothelial carcinoma
Nirmish Singla, Laura-Maria Krabbe, Ahmet M Aydin, et al.
World Journal of Urology
|
February 14, 2019
Prognostic significance of BAP1 expression in high-grade upper tract urothelial carcinoma: a multi-institutional study
Ahmet M Aydin, Nirmish Singla, Vandana Panwar, et al.
Urologic Oncology
|
December 22, 2019
PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomy
Hsin-Chih Yeh, Vitaly Margulis, Nirmish Singla, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Urologic Oncology
|
March 27, 2019
Expression and prognostic utility of PD-L1 in patients with squamous cell carcinoma of the bladder
Michael Owyong, Yair Lotan, Payal Kapur, et al.
Arxiv
|
June 10, 2024
Histopathology Based AI Model Predicts Anti-Angiogenic Therapy Response in Renal Cancer Clinical Trial
Jay Jasti, Hua Zhong, Vandana Panwar, et al.
Nature Communications
|
March 18, 2025
Histopathology based AI model predicts anti-angiogenic therapy response in renal cancer clinical trial
Jay Jasti, Hua Zhong, Vandana Panwar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 5, 2017
Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma
Thai Huu Ho, Payal Kapur, Jeanette E Eckel-Passow, et al.
Journal of Cellular Physiology
|
August 12, 2020
SPARC is a key mediator of TGF-β-induced renal cancer metastasis
Ji-Ming Bao, Qiang Dang, Chun-Jung Lin, et al.
Urologic Oncology
|
May 12, 2018
Multi-institutional evaluation of the prognostic significance of EZH2 expression in high-grade upper tract urothelial carcinoma
Nirmish Singla, Laura-Maria Krabbe, Ahmet M Aydin, et al.
World Journal of Urology
|
February 14, 2019
Prognostic significance of BAP1 expression in high-grade upper tract urothelial carcinoma: a multi-institutional study
Ahmet M Aydin, Nirmish Singla, Vandana Panwar, et al.
Urologic Oncology
|
December 22, 2019
PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomy
Hsin-Chih Yeh, Vitaly Margulis, Nirmish Singla, et al.
Page
of 2